The Effectiveness of a Succinate-Containing Medication in Accompanying Therapy of Comorbid Tuberculosis in a Penitentiary Institution

The aim of the study was to analyze the features of the organization of therapy for patients with HIV-associated tuberculosis (TB/HIV) and the effectiveness of pharmacotherapeutic approaches under the conditions of penitentiary institutions. Materials and methods: the data on the incidence and effec...

Full description

Saved in:
Bibliographic Details
Main Authors: V. M. Kolomiets, A. L. Kovalenko, E. P. Pavlenko, E. V. Talikova
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2020-12-01
Series:Антибиотики и Химиотерапия
Subjects:
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/763
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839591162999996416
author V. M. Kolomiets
A. L. Kovalenko
E. P. Pavlenko
E. V. Talikova
author_facet V. M. Kolomiets
A. L. Kovalenko
E. P. Pavlenko
E. V. Talikova
author_sort V. M. Kolomiets
collection DOAJ
description The aim of the study was to analyze the features of the organization of therapy for patients with HIV-associated tuberculosis (TB/HIV) and the effectiveness of pharmacotherapeutic approaches under the conditions of penitentiary institutions. Materials and methods: the data on the incidence and effectiveness of specialized medical care for TB/HIV patients were analyzed for a ten-year period in the population of penitentiary institutions of the Federal Penitentiary Service of one of the subjects of the Central Federal District of the Russian Federation. Therapy and examination of patients with TB/HIV was carried out in accordance with regulatory documents and using generally accepted diagnostic methods. The patients consulted the staff of the departments of the FSBEI HE KSMU to verify the diagnosis and correct treatment regimens. Results: the analysis showed that, despite the stabilization of the TB epidemic situation, the epidemiological indicators for comorbid TB/HIV are increasing in the penitentiary health sector, which is due to an increase in the number of HIV-infected patients. In order to intensify the treatment of patients with TB/HIV in the population of the penitentiary system, it is necessary to give priority to social and sanitary prevention, primarily in risk groups — HIV-infected and individuals with residual lung changes. The inclusion of Remaxol in the therapy regimens for TB/HIV patients promotes rapid relief of hepatotoxic reactions and, as a consequence, increases the effectiveness of the primary therapy, which is illustrated by clinical observation.
format Article
id doaj-art-173f2e287c634f58b09e0e98864a85d2
institution Matheson Library
issn 0235-2990
language Russian
publishDate 2020-12-01
publisher LLC "Publishing House OKI"
record_format Article
series Антибиотики и Химиотерапия
spelling doaj-art-173f2e287c634f58b09e0e98864a85d22025-08-03T13:04:48ZrusLLC "Publishing House OKI"Антибиотики и Химиотерапия0235-29902020-12-01659-10323610.37489/0235-2990-2020-65-9-10-32-36748The Effectiveness of a Succinate-Containing Medication in Accompanying Therapy of Comorbid Tuberculosis in a Penitentiary InstitutionV. M. Kolomiets0A. L. Kovalenko1E. P. Pavlenko2E. V. Talikova3Kursk State Medical UniversityInstitute of Toxicology of Federal Medico-Biological AgencyKursk State Medical UniversitySaint-Petersburg Medico-Social InstituteThe aim of the study was to analyze the features of the organization of therapy for patients with HIV-associated tuberculosis (TB/HIV) and the effectiveness of pharmacotherapeutic approaches under the conditions of penitentiary institutions. Materials and methods: the data on the incidence and effectiveness of specialized medical care for TB/HIV patients were analyzed for a ten-year period in the population of penitentiary institutions of the Federal Penitentiary Service of one of the subjects of the Central Federal District of the Russian Federation. Therapy and examination of patients with TB/HIV was carried out in accordance with regulatory documents and using generally accepted diagnostic methods. The patients consulted the staff of the departments of the FSBEI HE KSMU to verify the diagnosis and correct treatment regimens. Results: the analysis showed that, despite the stabilization of the TB epidemic situation, the epidemiological indicators for comorbid TB/HIV are increasing in the penitentiary health sector, which is due to an increase in the number of HIV-infected patients. In order to intensify the treatment of patients with TB/HIV in the population of the penitentiary system, it is necessary to give priority to social and sanitary prevention, primarily in risk groups — HIV-infected and individuals with residual lung changes. The inclusion of Remaxol in the therapy regimens for TB/HIV patients promotes rapid relief of hepatotoxic reactions and, as a consequence, increases the effectiveness of the primary therapy, which is illustrated by clinical observation.https://www.antibiotics-chemotherapy.ru/jour/article/view/763morbiditytuberculosis/hivanti-tuberculosis therapyhepatoprotectorsremaxol
spellingShingle V. M. Kolomiets
A. L. Kovalenko
E. P. Pavlenko
E. V. Talikova
The Effectiveness of a Succinate-Containing Medication in Accompanying Therapy of Comorbid Tuberculosis in a Penitentiary Institution
Антибиотики и Химиотерапия
morbidity
tuberculosis/hiv
anti-tuberculosis therapy
hepatoprotectors
remaxol
title The Effectiveness of a Succinate-Containing Medication in Accompanying Therapy of Comorbid Tuberculosis in a Penitentiary Institution
title_full The Effectiveness of a Succinate-Containing Medication in Accompanying Therapy of Comorbid Tuberculosis in a Penitentiary Institution
title_fullStr The Effectiveness of a Succinate-Containing Medication in Accompanying Therapy of Comorbid Tuberculosis in a Penitentiary Institution
title_full_unstemmed The Effectiveness of a Succinate-Containing Medication in Accompanying Therapy of Comorbid Tuberculosis in a Penitentiary Institution
title_short The Effectiveness of a Succinate-Containing Medication in Accompanying Therapy of Comorbid Tuberculosis in a Penitentiary Institution
title_sort effectiveness of a succinate containing medication in accompanying therapy of comorbid tuberculosis in a penitentiary institution
topic morbidity
tuberculosis/hiv
anti-tuberculosis therapy
hepatoprotectors
remaxol
url https://www.antibiotics-chemotherapy.ru/jour/article/view/763
work_keys_str_mv AT vmkolomiets theeffectivenessofasuccinatecontainingmedicationinaccompanyingtherapyofcomorbidtuberculosisinapenitentiaryinstitution
AT alkovalenko theeffectivenessofasuccinatecontainingmedicationinaccompanyingtherapyofcomorbidtuberculosisinapenitentiaryinstitution
AT eppavlenko theeffectivenessofasuccinatecontainingmedicationinaccompanyingtherapyofcomorbidtuberculosisinapenitentiaryinstitution
AT evtalikova theeffectivenessofasuccinatecontainingmedicationinaccompanyingtherapyofcomorbidtuberculosisinapenitentiaryinstitution
AT vmkolomiets effectivenessofasuccinatecontainingmedicationinaccompanyingtherapyofcomorbidtuberculosisinapenitentiaryinstitution
AT alkovalenko effectivenessofasuccinatecontainingmedicationinaccompanyingtherapyofcomorbidtuberculosisinapenitentiaryinstitution
AT eppavlenko effectivenessofasuccinatecontainingmedicationinaccompanyingtherapyofcomorbidtuberculosisinapenitentiaryinstitution
AT evtalikova effectivenessofasuccinatecontainingmedicationinaccompanyingtherapyofcomorbidtuberculosisinapenitentiaryinstitution